ReMeDy: a platform for integrating and sharing published stem cell research data with a focus on iPSC trials is a dataset published in Database (2021). On theSindex it has a DataRank of 0.404, placing it in the top 45.5% of the data-sharing corpus. It has been cited 10 times, with 2 citing works in its 1-hop citation network.
Ranks in the top 46% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0.0439
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
NIH
Grant: UL1TR001433 and OT2HL147606
NHLBI NIH HHS
Grant: OT2 HL147606
NCATS NIH HHS
Grant: UL1 TR001433
NCATS NIH HHS
Grant: UL1 TR004419
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 3OT2HL147606-01S1
Enhancing the Development of New Regenerative Medicine Therapies:Proposal to Build a Robust Clinical Research Development and Data Hub
National Institutes of Health
Grant: 5UL1TR001433-02
MSHS Translational Science Hub
FWCI
0.67
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals